drugset / Trial / NCT01808911

Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study)

NCT01808911 ↗

Phase 3 Completed 110 enrolled University Hospital, Rouen
RandomizedParallel-groupTreatment

Summary

CREHA project is a study comparing steroid combined with cyclophosphamide versus steroid combined with rituximab in patients with acquired haemophilia. The study will test the hypothesis that steroid combined with cyclophosphamide is more effective than steroid plus rituximab for FVIII inhibitor eradication in acquired haemophilia.

Timeline

Start
2012-05
Primary completion
2021-01-14
Completion
2021-01-14

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cyclophosphamide Other / unclassified 2 mg/kg Oral
Subject Rituximab Monoclonal antibody 375 mg/m2 —
Comparator Prednisone Other / unclassified 1 mg/kg —

Indications